EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy

Deepti Vellaichamy Manian, Sayantani B Sindher, Nasim Khavari, Alfred D Doyle, R Sharon Chinthrajah, Benjamin L Wright

The Journal of Allergy and Clinical Immunology: In Practice · 2026-08 · 14 (8) · 1736-1746

DOI: 10.1016/j.jaip.2026.06.025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-08. Verfasst von Deepti Vellaichamy Manian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Kaiser Permanente, San Jose, Calif. Electronic address: allergydocdee@gmail.com. Hauptthemen laut MEDLINE: Food Hypersensitivity, Eosinophilic Esophagitis, Desensitization, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Levin Family Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgE-mediated food allergy and eosinophilic esophagitis (EoE) represent distinct yet interconnected manifestations of food-induced immune dysregulation. Rather than separate entities, emerging evidence supports a model that is on a continuum, in which clinical phenotypes are determined by antigen exposure patterns, dose, chronicity, and individual immune responses. This relationship has critical implications for food allergy immunotherapy, particularly oral immunotherapy. Among children with IgE-mediated food allergy, EoE prevalence is nearly 100-fold higher than the general population at 4.7%. During oral immunotherapy, gastrointestinal symptoms are common, with confirmed EoE developing in 1% to 10% of participants. Mechanistically, antigen avoidance favors IgE-mediated responses through T follicular helper cells, whereas sustained exposure promotes TH2-driven esophageal inflammation via pathogenic effector TH2 cells. Regulatory T-cell dysfunction appears central to this phenotypic switching. Clinical management requires risk stratification, systematic monitoring strategies, and individualized protocols that balance desensitization benefits against esophageal inflammation risks. Future directions include noninvasive diagnostic biomarkers, biologic therapies, and evidence-based prevention strategies. Understanding the food allergy-EoE continuum is essential for optimizing safety and efficacy of food allergen immunotherapy while minimizing complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityEosinophilic EsophagitisDesensitization, ImmunologicHumansImmunoglobulin EAnimalsTh2 CellsAllergens

Stichwörter der Autor:innen

EosinophilEosinophilic esophagitisFood allergyOral immunotherapy

Substanzen

Immunoglobulin EAllergens

Autor:innen und Institutionen

  • Division of Allergy and Immunology, Kaiser Permanente, San Jose, Calif. Electronic address: allergydocdee@gmail.com.
  • Sean N Parker Center for Allergy and Asthma Research at Stanford University, Stanford, Calif.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University School of Medicine, Stanford, Calif.
  • Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Ariz.
  • Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Ariz; Division of Allergy and Immunology, Phoenix Children's, Phoenix, Ariz.

Förderung

  • NIAID NIH HHS
  • Levin Family Foundation
  • National Institutes of Health
  • Nestlé
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Vellaichamy Manian, D., Sindher, S. B., Khavari, N., Doyle, A. D., Chinthrajah, R. S., & Wright, B. L. (2026). The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice, 14(8), 1736-1746. https://doi.org/10.1016/j.jaip.2026.06.025

Vancouver

Vellaichamy Manian D, Sindher SB, Khavari N, Doyle AD, Chinthrajah RS, Wright BL. The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(8):1736-1746. doi:10.1016/j.jaip.2026.06.025

BibTeX
@article{VellaichamyManian2026,
  author = {Vellaichamy Manian, Deepti and Sindher, Sayantani B and Khavari, Nasim and Doyle, Alfred D and Chinthrajah, R Sharon and Wright, Benjamin L},
  title = {The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {1736--1746},
  doi = {10.1016/j.jaip.2026.06.025}
}
Kostenlos starten →